HT update: spotlight on estradiol/norethindrone acetate combination therapy

References

• ACOG Coronary Heart Disease SupplementObstet Gynecol20041041S48S15458927
   PubMed Web of Science ®Google Scholar
• ACOG Stroke SupplementObstet Gynecol2004104497S105S
   Google Scholar
• ACOG Venous Thromboembolic DiseaseObstet Gynecol2004104118S27S15458942
   PubMedGoogle Scholar
• AdlerGYoungDGalantRA multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptomsGynecol Obstet Invest2005592121915753617
   PubMed Web of Science ®Google Scholar
• Al-AzzawiFWhaabMEstrogen and colon cancer:current issuesClimacteric2002531411974557
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyCancer facts and figures2003Atlanta, GAACS
   Google Scholar
• ArcherDFFurstKTippingDA randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopauseObstet Gynecol19999449850310511348
   PubMed Web of Science ®Google Scholar
• ArabiAGarneroPPorcherRChanges in body composition during post-menopausal hormone therapy:a 2 year prospective studyHuman Reprod200318174752
   PubMed Web of Science ®Google Scholar
• BaerugUWingeTNordlandGDo combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?Climacteric199812192811907946
   PubMedGoogle Scholar
• BeastonGTOn the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative casesLancet189621047
   Google Scholar
• BrettKMReubenCAPrevalence of estrogen or estrogen-progestin hormone therapy useObstet Gynecol20031021240914662210
   PubMed Web of Science ®Google Scholar
• Claudia StahlbergCAnette Tønnes PedersenATElsebeth LyngeEHormone replacement therapy and risk of breast cancer:the role of progestinsActa Obstetricia et Gynecologica Scandinavica20038233544
   Web of Science ®Google Scholar
• ClarkJHSchraderWTO’MalleyBWMechanism of action of steroid hormonesWilliams Textbook of Endocrinology19923590
   Google Scholar
• ClarkSCKelleherJLloyd-JonesHA study of hormone replacement therapy in postmenopausal women with ischaemic heart disease:the Papworth HRT atherosclerosis studyBJOG200210910566212269682
   PubMed Web of Science ®Google Scholar
• ChristiansenCChristensenMSMcNairPPrevention of postmenopausal bone loss: controlled 2 year study in 315 normal femalesEur J Clin Invest19802808226
   Google Scholar
• ChristiansenCChristensenMSTransboelIBone mass in postmenopausal women after withdrawal of oestrogen/getsten replacement therapyLancet19811459616110089
   PubMed Web of Science ®Google Scholar
• ChristiansenCRiisB17β-Estradiol and continuous norethisterone:a unique treatment for established osteoporosis in elderly womenJ Clin Endocrinol Metab199071836412205624
   PubMed Web of Science ®Google Scholar
• CoyleDCranneyATugwellPEconomic evaluation of norethisterone acetate/ethinyl estradiol (FemHRT) for women with menopausal symptomsPharmacoeconomics200321661912807367
   PubMed Web of Science ®Google Scholar
• Executive SummaryObstet Gynecol2004104Suppl1S4S15458927
   PubMedGoogle Scholar
• FiorelliGPicarielloLMartinetiVEstrogen synthesis in human colon cancer epithelial cellsJ Steroid Biochem Mol Biol1999712233010704911
   PubMed Web of Science ®Google Scholar
• FosberyWHSSevere climacteric flushings successfully treated by ovarian extractBr Med J1897i1039
   Google Scholar
• GambaccianiMCiaponiMCappagliEffects of low-dose, continuous combined estradiol and norithsterone acetate on menopausal quality of life in early postmenopausal womenMaturitas2003441576312590012
   PubMed Web of Science ®Google Scholar
• GradyDHerringtonDBittnerVCardiovascular disease outcomes during 6.8 years of hormone therapy:Heart and Estrogen/progestin Replacement Study follow-up (HERS II)JAMA2002288495712090862
   PubMed Web of Science ®Google Scholar
• GrodsteinFNewcombPAStampferMJPostmenopausal hormone therapy and the risk of colorectal cancer:a review and meta-analysisAm J Med19991065748210335731
   PubMed Web of Science ®Google Scholar
• HingEBrettKMChanges in U.S. prescribing patterns of menopausal hormone therapy, 2001–3Obstet Gynecol2006108334016816053
   PubMed Web of Science ®Google Scholar
• HolmbergLAndersonHHABITS steering and data monitoring committeesHABITS, a randomized comparison:trial stoppedLancet2004363453514962527
   PubMed Web of Science ®Google Scholar
• JohnsonJVDavidsonMArcherDPostmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapyMenopause200293511791080
   PubMed Web of Science ®Google Scholar
• KurmanRJFelixJCArcherDFNorethindrone acetate and estradiol-induced endometrial hyperplasiaObstet Gynecol200096373910960628
   PubMed Web of Science ®Google Scholar
• MansonJEAllisonMARossouwJEEstrogen therapy and coronary-artery calcificationN Engl J Med2007356259160217582069
   PubMed Web of Science ®Google Scholar
• McClungMEfficacy of Activelle to increase bone mineral density in postmenopausal womenBone199823Suppl
   Google Scholar
• PikeMCSpicerDVDahmoushLEstrogens, progestogens, normal breast cell proliferation, and breast cancer riskEpidemi Rev1993151735
   PubMed Web of Science ®Google Scholar
• PoppAWBodmerCSennCPrevention of postmenopausal bone loss with long-cycle hormone replacement therapyMaturitas20065319120016368472
   PubMed Web of Science ®Google Scholar
• PortmanDJSymonsJPWilbornWA randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol aloneAm J Obstet Gynecol20031883344212592236
   PubMed Web of Science ®Google Scholar
• RavnPBidstrupMWasnichRDAlendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the Early Postmenopausal Intervention Cohort StudyAnn Intern Med19991319354210610644
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women’s Health Initiative randomized controlled trialJAMA20022883213312117397
   PubMed Web of Science ®Google Scholar
• RouxCPelissierCFechtenbaumRandomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone lossOsteoporos Int200213241811991445
   PubMed Web of Science ®Google Scholar
• RowanJPSimonJASperoffLEffects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 μg) in women with postmenopausal symptoms:Updated analysis of three randomized controlled trialsClin Ther2006289213216860174
   PubMed Web of Science ®Google Scholar
• SimonSASymonsJPfemhrt Study InvestigatorsUnscheduled bleeding during initiation of continuous combined hormone replacement therapy:a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogensMenopause20018321711528357
   PubMed Web of Science ®Google Scholar
• SimonJAWysockiSBrandmanJA comparison of therapy continuation rates of different hormone replacement agents:a 9-month retrospective, longitudinal analysis of pharmacy claims among new usersMenopause200310374412544675
   PubMed Web of Science ®Google Scholar
• SmithYRLoveTPersadCCImpact of combined estradiol and norethindrone therapy on visuo-spatial working memory assessed by functional magnetic resonance imagingJ Clin Endocrinol Metab20069144768116912129
   PubMed Web of Science ®Google Scholar
• SperoffLFritzMAClinical Gynecologic Endocrinology and Infertility2005BaltimoreLippincott, Williams and Wilkins
   Google Scholar
• StahlbergCPedersonATLyngeEHormone replacement therapy and risk of breast cancer:the role of progestinsActa Obstet Gynecol Scand20038233544
   Web of Science ®Google Scholar
• VerheulHACoelingh-BenninkHJKenemansPEffects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapiesMaturitas20003611710989237
   PubMed Web of Science ®Google Scholar
• WeiderpassEAdamiHOBaronJAUse of oral contraceptives and endometrial cancer risk (Sweden)Cancer Causes Control1999102778410482486
   PubMed Web of Science ®Google Scholar
• WellsMSturdeeDWBarlowDHEffect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up studyBMJ20023251512098707
   PubMed Web of Science ®Google Scholar
• YildirimGTugrulSUsluHEffects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleedingArch Gynecol Obstet20062732687316315025
   PubMedGoogle Scholar